Pharmacokinetic and safety study of subcutaneously administered weekly ING-1, a human engineered™ monoclonal antibody targeting human EpCAM, in patients with advanced solid tumors
| Autor: | Goel, S. *, Bauer, R.J., Desai, K., Bulgaru, A., Iqbal, T., Strachan, B.-K., Kim, G., Kaubisch, A., Vanhove, G.F., Goldberg, G., Mani, S. * |
|---|---|
| Zdroj: | In Annals of Oncology October 2007 18(10):1704-1707 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|